Thermo Fisher Scientific

http://www.chromatographyonline.com/lcgc_w/modernizing


	Learn how to approach method speed up, optimization and transfer when modernizing pharmacopeial monograph methods. This webcast will discuss the use of superficially porous particle (SPP) columns on an optimized UHPLC system to increase analytical throughput.  Once an HPLC method is established, the work of instrument-to-instrument transfer of the method can be challenging. Learn about the key factors that need to be considered for method transfer and hear about the compliant hardware features to facilitate transferring methods built into modern HPLC and UHPLC systems.

		Learn how to increase throughput and optimize HPLC methods by learning the basics of pharmacopeia modernization and how to comply with modernized methods

		Learn about key factors which contribute to successful method transfer

		Discover compliant hardware features that facilitate method transfer built into modern HPLC and UHPLC systems

Dr. James Grinias, Assistant Professor, Department of Chemistry & Biochemistry, Rowan University

	Dr. Frank Steiner, Sr. Manager of Product Applications & Scientific Advisor, Thermo Fisher Scientific

 Tuesday, Aug. 25, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

	On demand available after final airing until Aug. 25, 2021

Webcasts

Listen and learn as Dr. James Grinias from Rowan University and Dr. Frank Steiner from Thermo Fisher Scientific discuss approaches and considerations to modernizing HPLC methods to increase throughput using superficially porous particles. They also discuss challenges in method transfer and describe new compliant hardware technologies built into the modern HPLC and UHPLC systems.

Live: Tuesday, Aug. 25, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

On demand available after final airing until Aug. 25, 2021

Building a More Efficient Routine Lab: Approaches to Modernizing HPLC Methods with New Technologies

https://www.pharmtech.com/pt_w/injectable_implants

Injectable implants offer several advantages as drug delivery systems including site-specific release and high patient compliance. Hot-melt extrusion (HME) is an ideal method for the manufacture of such implants because it can be scalable from early R&D to commercial manufacturing, often with a single instrument. HME can also be done in a continuous manufacturing environment. Watch this webcast for an overview of implant types, materials, and scale-up from development to full-scale manufacturing.

Understand implant types and key applications

Learn how HME is used to produce injectable implants

See how instruments can be setup from R&D through commercial manufacturing

Dirk Leister, Manager, Applications & Customer Support for Extrusion and Compounding, Thermo Fisher Scientific

Tuesday, Sept. 22, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST

On demand available after airing until Sept. 22, 2021

The promises of the digital lab are enticing but getting there can seem daunting. The good news is that you can start today. It’s simply about implementation, and not waiting for innovation.

Live: Tuesday, Sept. 22, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST

On demand available after airing until Sept. 22, 2021

Injectable Implants: Manufacturing Advanced Medicines with Hot-Melt Extrusion

Articles

An overview of data processing in the HR MAM workflow and demonstration of software for flexibility in different phases of drug development and manufacturing

Performing the biopharmaceutical multi-attribute method

https://www.pharmtech.com/pt/production_efficency

Reducing costs and improving efficiency have always been a goal, but these needs are increasingly critical for pharmaceutical companies in the current pandemic era. Near-infrared (NIR) spectroscopy is a non-destructive analytical tool that provides solutions from drug development to the QA/QC lab, and in at-line, on-line, or continuous manufacturing processes. Its potential in the pharmaceutical manufacturing value chain is still expanding.

This webcast will highlight NIR’s incredible capabilities across a variety of drug forms, in regulatory compliance, for GMP environments, and more.

NIR spectroscopy as an alternative to wet chemistry and HPLC/GC method with the same accuracy but faster, cheaper, and non-destructively

What to look for in a hardware-software platform to assure drug formulation integrity as well as data integrity

Considerations for integrating NIR technology into the analytical workflow within pharma

Mike Garry, Sr. Product Manager, NIR Spectroscopy Thermo Fisher Scientific

Wednesday, Sept. 9, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

On demand available after airing until Sept. 9, 2021

Near infrared (NIR) spectroscopy to the rescue: See how this vital process analytical technology tool can improve efficiency and cut costs in your pharmaceutical QC processes.

Live: Wednesday, Sept. 9, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

On demand available after airing until Sept. 9, 2021


NIR to the Rescue: Production Efficiency and Cost Savings for Pharma

The Thermo Scientific Vanquish Duo system for Dual LC enables two sample runs concurrently, so samples to run in half the time, improving pharmaceutical drug analysis.
